These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26050385)

  • 21. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    AIDS Patient Care STDS; 2015 Jan; 29(1):33-42. PubMed ID: 25375792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
    Yombi JC; Mertes H
    AIDS Rev; 2018; 20(3):131-140. PubMed ID: 30264827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, Benin.
    Geidelberg L; Mitchell KM; Alary M; Mboup A; Béhanzin L; Guédou F; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Silhol R; Cianci F; Vickerman P; Boily MC
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):e28-e42. PubMed ID: 33105397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARV-based HIV prevention for women - where we are in 2014.
    Mastro TD; Sista N; Abdool-Karim Q
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Curlin ME; Na-Pompet S; Warapronmongkholkul A; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Choopanya K;
    AIDS; 2015 Apr; 29(7):819-24. PubMed ID: 25985403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
    de Loenzien M
    Sante; 2009; 19(3):141-8. PubMed ID: 20185390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is HIV prevention creating new biosocialities among gay men? Treatment as prevention and pre-exposure prophylaxis in Canada.
    Girard G; Patten S; LeBlanc MA; Adam BD; Jackson E
    Sociol Health Illn; 2019 Mar; 41(3):484-501. PubMed ID: 30450606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
    Kalapila AG; Marrazzo J
    Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):572-578. PubMed ID: 27273843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "In reality, it is complex and difficult": UK nurses' perspectives on "treatment as prevention" within HIV care.
    Evans C; Bennett J; Croston M; Brito-Ault N; Bruton J
    AIDS Care; 2015; 27(6):753-7. PubMed ID: 25650545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterosexual transmission of HIV and related risk factors among serodiscordant couples in Henan province, China.
    Wang L; Wang L; Smith MK; Li LM; Ming S; Lü J; Cao WH; He WS; Zhou JP; Wang N
    Chin Med J (Engl); 2013; 126(19):3694-700. PubMed ID: 24112166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.
    Heffron R; Ngure K; Odoyo J; Bulya N; Tindimwebwa E; Hong T; Kidoguchi L; Donnell D; Mugo NR; Bukusi EA; Katabira E; Asiimwe S; Morton J; Morrison S; Haugen H; Mujugira A; Haberer JE; Ware NC; Wyatt MA; Marzinke MA; Frenkel LM; Celum C; Baeten JM;
    Gates Open Res; 2017; 1():3. PubMed ID: 29355231
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination HIV prevention options for young women in Africa.
    Baxter C; Abdool Karim S
    Afr J AIDS Res; 2016 Jul; 15(2):109-21. PubMed ID: 27399041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.
    Holt M
    Cult Health Sex; 2015; 17(4):428-39. PubMed ID: 25270549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels.
    Hoffmann CJ; Gallant JE
    Infect Dis Clin North Am; 2014 Dec; 28(4):549-61. PubMed ID: 25287588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key Population Hotspots in Nigeria for Targeted HIV Program Planning: Mapping, Validation, and Reconciliation.
    Lo J; Nwafor SU; Schwitters AM; Mitchell A; Sebastian V; Stafford KA; Ezirim I; Charurat M; McIntyre AF
    JMIR Public Health Surveill; 2021 Feb; 7(2):e25623. PubMed ID: 33616537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.